Ireland
--:--IST
Latest
Clinical Trials in Israel / NCT06476626
Starting soon Not applicable

Maternal Reflective Functioning During the Transition to Motherhood

NCT06476626 · tracked via the Priya Life Science Israel tracker
Phase
Not applicable
Started
2024-07-15
Last updated
2024-07-09

Condition(s) studied

PregnancyPrimiparous Women

Investigational drug(s) / intervention(s)

Maternal Reflective Function Workshop

Maternal Reflective Function Workshop: 4 session group online intervention focused on psycho-educational knowledge regarding emotional regulation and specifically MRF. group size- up to 15 participants. 2 sessions will be during pregnancy and 2 sessions will taken place 1 and 3 months after birth.

Study summary

The goal of this clinical trial is to learn about Maternal Reflective Function (MRF) during the transition to motherhood. The main questions it aims to answer are:

Does MRF mediates the connection between risk factors for mental health difficulties during first pregnancy and motherhood (the transition to motherhood) and outcomes related to the mother, the infant, and their relationship.

Participants will:

Answer questionnaires and clinical interviews during pregnancy and after birth of the first child (twice at third trimester, 1 and 3 months after birth).

intervention group will participate in an online short intervention to enhance MRF.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * pregnant women in 27-30 weeks pregnant in enrollment * speak read and understand Hebrew * Has a connection to internet and ZOOM platform. * Ready to participate in a group workshop Exclusion Criteria: * Women who can\'t participate in a online workshop due to physical or mental health difficulties.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Haifa Haifa Israel

More University of Haifa trials in Israel

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06476626 on ClinicalTrials.gov ↗ ← All trials in Israel